P636-0607 Screening compound: N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}-1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidine-4-carboxamide

P636-0607 Screening compound: N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}-1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidine-4-carboxamide
P636-0607 Screening compound: N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}-1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P636-0607
N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}-1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P636-0607

Molecular Formula

C23H31FN6O2 (C23 H31 FN6 O2)

Compound Name

N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}-1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidine-4-carboxamide

IUPAC name

N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}-1-(1-methyl-6-oxo-16-dihydropyridazin-4-yl)piperidine-4-carboxamide

SMILES

CN1N=CC(N(CC2)CCC2C(NCCN(CC2)CCN2c(cccc2)c2F)=O)=CC1=O

InChI

InChI=1S/C23H31FN6O2/c1-27-22(31)16-19(17-26-27)29-9-6-18(7-10-29)23(32)25-8-11-28-12-14-30(15-13-28)21-5-3-2-4-20(21)24/h2-5,16-18H,6-15H2,1H3,(H,25,32)

InChI Key

KKDMXVIBHXSEIW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31993054

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

442.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.186

Distribution Coefficient, logD

0.920

Water Solubility, LogSw

-1.87

Polar Surface Area

63.641

Acid Dissociation Constant (pKa)

13.35

Base Dissociation Constant (pKb)

5.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.17

P636-0607 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P636-0607 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P636-0607?
Check Price and Availability of P636-0607, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P636-0607 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P636-0607
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P636-0607
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P636-0607 available by request